GCP
ANAB icon

GSA Capital Partners’s AnaptysBio ANAB Stock Holding History

GSA Capital Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,695
Closed -$518K – 1686
2025
Q4 		$518K Sell
10,695
-26,579
-71% -$1.04M 0.04% 780
2025
Q3 		$1.14M Sell
37,274
-32,525
-47% -$746K 0.1% 319
2025
Q2 		$1.55M Buy
+69,799
New +$1.46M 0.11% 218
2024
Q4 		– Sell
-17,140
Closed -$574K – 1579
2024
Q3 		$574K Buy
+17,140
New +$586K 0.04% 824
2023
Q3 		– Sell
-18,721
Closed -$381K – 1470
2023
Q2 		$381K Buy
+18,721
New +$380K 0.04% 906
2021
Q4 		– Sell
-14,583
Closed -$395K – 1391
2021
Q3 		$395K Buy
+14,583
New +$370K 0.04% 842
2021
Q1 		– Sell
-13,664
Closed -$294K – 1077
2020
Q4 		$294K Sell
13,664
-12,270
-47% -$298K 0.05% 747
2020
Q3 		$383K Buy
+25,934
New +$468K 0.06% 571
2020
Q2 		– Sell
-12,178
Closed -$172K – 605
2020
Q1 		$172K Sell
12,178
-35,934
-75% -$545K 0.04% 799
2019
Q4 		$782K Buy
48,112
+35,078
+269% +$830K 0.09% 347
2019
Q3 		$456K Buy
+13,034
New +$620K 0.06% 611

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GSA Capital Partners's ANAB Position: Q1 2026 in Review

GSA Capital Partners sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 10,695 shares — an estimated $518K sold.

GSA Capital Partners first reported a position in ANAB in Q3 2019 and held it in 11 quarters. The position peaked at $1.55M in Q2 2025. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • GSA Capital Partners reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 10,695 AnaptysBio shares in Q1 2026, an estimated $518K.
  • GSA Capital Partners first reported a position in AnaptysBio in Q3 2019 and held it in 11 quarters.
  • GSA Capital Partners's AnaptysBio position peaked at $1.55M in Q2 2025.
  • 208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.